580 related articles for article (PubMed ID: 33921908)
1. Elucidating Role of Reactive Oxygen Species (ROS) in Cisplatin Chemotherapy: A Focus on Molecular Pathways and Possible Therapeutic Strategies.
Mirzaei S; Hushmandi K; Zabolian A; Saleki H; Torabi SMR; Ranjbar A; SeyedSaleh S; Sharifzadeh SO; Khan H; Ashrafizadeh M; Zarrabi A; Ahn KS
Molecules; 2021 Apr; 26(8):. PubMed ID: 33921908
[TBL] [Abstract][Full Text] [Related]
2. Nrf2 signaling pathway in cisplatin chemotherapy: Potential involvement in organ protection and chemoresistance.
Mirzaei S; Mohammadi AT; Gholami MH; Hashemi F; Zarrabi A; Zabolian A; Hushmandi K; Makvandi P; Samec M; Liskova A; Kubatka P; Nabavi N; Aref AR; Ashrafizadeh M; Khan H; Najafi M
Pharmacol Res; 2021 May; 167():105575. PubMed ID: 33771701
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of PDGFR by CP-673451 induces apoptosis and increases cisplatin cytotoxicity in NSCLC cells via inhibiting the Nrf2-mediated defense mechanism.
Yang Y; Deng Y; Chen X; Zhang J; Chen Y; Li H; Wu Q; Yang Z; Zhang L; Liu B
Toxicol Lett; 2018 Oct; 295():88-98. PubMed ID: 29857117
[TBL] [Abstract][Full Text] [Related]
4. Lung cancer cells and their sensitivity/resistance to cisplatin chemotherapy: Role of microRNAs and upstream mediators.
Ashrafizadeh M; Zarrabi A; Hushmandi K; Hashemi F; Moghadam ER; Owrang M; Hashemi F; Makvandi P; Goharrizi MASB; Najafi M; Khan H
Cell Signal; 2021 Feb; 78():109871. PubMed ID: 33279671
[TBL] [Abstract][Full Text] [Related]
5. Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy.
Mirzaei S; Gholami MH; Hashemi F; Zabolian A; Hushmandi K; Rahmanian V; Entezari M; Girish YR; Sharath Kumar KS; Aref AR; Makvandi P; Ashrafizadeh M; Zarrabi A; Khan H
Life Sci; 2021 Jul; 277():119430. PubMed ID: 33789144
[TBL] [Abstract][Full Text] [Related]
6. Loss of Scribble confers cisplatin resistance during NSCLC chemotherapy via Nox2/ROS and Nrf2/PD-L1 signaling.
Wang N; Song L; Xu Y; Zhang L; Wu Y; Guo J; Ji W; Li L; Zhao J; Zhang X; Zhan L
EBioMedicine; 2019 Sep; 47():65-77. PubMed ID: 31495720
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin induces autophagy-associated apoptosis in human oral squamous cell carcinoma (OSCC) mediated in part through reactive oxygen species.
Magnano S; Hannon Barroeta P; Duffy R; O'Sullivan J; Zisterer DM
Toxicol Appl Pharmacol; 2021 Sep; 427():115646. PubMed ID: 34274415
[TBL] [Abstract][Full Text] [Related]
8. Emodin Enhances the Chemosensitivity of Endometrial Cancer by Inhibiting ROS-Mediated Cisplatin-resistance.
Ding N; Zhang H; Su S; Ding Y; Yu X; Tang Y; Wang Q; Liu P
Anticancer Agents Med Chem; 2018; 18(7):1054-1063. PubMed ID: 29256357
[TBL] [Abstract][Full Text] [Related]
9. Emerging role of NRF2 in ROS-mediated tumor chemoresistance.
Xue D; Zhou X; Qiu J
Biomed Pharmacother; 2020 Nov; 131():110676. PubMed ID: 32858502
[TBL] [Abstract][Full Text] [Related]
10. Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways.
Wang X; Gong Q; Song C; Fang J; Yang Y; Liang X; Huang X; Liu J
Toxicol Appl Pharmacol; 2021 May; 418():115484. PubMed ID: 33716044
[TBL] [Abstract][Full Text] [Related]
11. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors.
Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T
Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
13. DUOXA1-mediated ROS production promotes cisplatin resistance by activating ATR-Chk1 pathway in ovarian cancer.
Meng Y; Chen CW; Yung MMH; Sun W; Sun J; Li Z; Li J; Li Z; Zhou W; Liu SS; Cheung ANY; Ngan HYS; Braisted JC; Kai Y; Peng W; Tzatsos A; Li Y; Dai Z; Zheng W; Chan DW; Zhu W
Cancer Lett; 2018 Aug; 428():104-116. PubMed ID: 29704517
[TBL] [Abstract][Full Text] [Related]
14. Tea polyphenols modulate antioxidant redox system on cisplatin-induced reactive oxygen species generation in a human breast cancer cell.
Periasamy VS; Alshatwi AA
Basic Clin Pharmacol Toxicol; 2013 Jun; 112(6):374-84. PubMed ID: 23145928
[TBL] [Abstract][Full Text] [Related]
15. Emodin enhances cisplatin-induced cytotoxicity in human bladder cancer cells through ROS elevation and MRP1 downregulation.
Li X; Wang H; Wang J; Chen Y; Yin X; Shi G; Li H; Hu Z; Liang X
BMC Cancer; 2016 Aug; 16():578. PubMed ID: 27485374
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced ROS promotes mitochondrial fission and cisplatin chemosensitivity via HIF-1α/Mff regulation in head and neck squamous cell carcinoma.
Wu K; Mao YY; Chen Q; Zhang B; Zhang S; Wu HJ; Li Y
Cell Oncol (Dordr); 2021 Oct; 44(5):1167-1181. PubMed ID: 34460078
[TBL] [Abstract][Full Text] [Related]
17. Suppression of SESN1 reduces cisplatin and hyperthermia resistance through increasing reactive oxygen species (ROS) in human maxillary cancer cells.
Narita N; Ito Y; Takabayashi T; Okamoto M; Imoto Y; Ogi K; Tokunaga T; Matsumoto H; Fujieda S
Int J Hyperthermia; 2018 Dec; 35(1):269-278. PubMed ID: 30300027
[TBL] [Abstract][Full Text] [Related]
18. Reactive oxygen species-mediated synergistic and preferential induction of cell death and reduction of clonogenic resistance in breast cancer cells by combined cisplatin and FK228.
Pluchino LA; Choudhary S; Wang HC
Cancer Lett; 2016 Oct; 381(1):124-32. PubMed ID: 27477899
[TBL] [Abstract][Full Text] [Related]
19. A Novel Platinum-Maurocalcine Conjugate Induces Apoptosis of Human Glioblastoma Cells by Acting through the ROS-ERK/AKT-p53 Pathway.
Aroui S; Dardevet L; Ben Ajmia W; de Boisvilliers M; Perrin F; Laajimi A; Boumendjel A; Kenani A; Muller JM; De Waard M
Mol Pharm; 2015 Dec; 12(12):4336-48. PubMed ID: 26465677
[TBL] [Abstract][Full Text] [Related]
20. Natural borneol sensitizes human glioma cells to cisplatin-induced apoptosis by triggering ROS-mediated oxidative damage and regulation of MAPKs and PI3K/AKT pathway.
Cao WQ; Zhai XQ; Ma JW; Fu XQ; Zhao BS; Zhang P; Fu XY
Pharm Biol; 2020 Dec; 58(1):72-79. PubMed ID: 31875760
[No Abstract] [Full Text] [Related]
[Next] [New Search]
